The FDA has cleared an augmented reality platform for real-time use during brain surgery—which its developer, Medivis, ...
MapLight Therapeutics is the latest biotech to want a turn with Alphabet’s AI spinout SandboxAQ. | MapLight Therapeutics is ...
Sanofi is back with its second pact of the day, this time announcing a licensing deal for a South Korean biotech’s antibody ...
The biotech’s lead asset, AVD-104, failed to beat Astellas’ Izervay at slowing the rate of retina lesion growth, the primary ...
Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that ...